Quick Answer
Insight Molecular Diagnostics Inc. reported Total Revenue of $4.05 million for fiscal year 2025.
Insight Molecular Diagnostics Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $4.05M | +115.6% |
| 2024 | $1.88M | +25.1% |
| 2023 | $1.50M | +56.9% |
| 2022 | $958.0K | -56.4% |
| 2021 | $2.20M | +80.8% |
| 2020 | $1.22M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $260.0K | +126.1% | -49.8% |
| June 30, 2025 | $518.0K | +398.1% | -75.8% |
| March 31, 2025 | $2.14M | +1114.8% | +1759.1% |
| September 30, 2024 | $115.0K | -73.2% | +10.6% |
| June 30, 2024 | $104.0K | -77.5% | -40.9% |
| March 31, 2024 | $176.0K | -40.7% | -59.0% |
| September 30, 2023 | $429.0K | +540.3% | -7.3% |
| June 30, 2023 | $463.0K | +95.4% | +55.9% |
- Insight Molecular Diagnostics Inc. showed an increase of +115.6% in Total Revenue compared to the prior fiscal year.
- Over the 2020–2025 period, Insight Molecular Diagnostics Inc.’s total revenue has grown by 233.5% (from $1.22 million to $4.05 million).
- The most recent figure is from Insight Molecular Diagnostics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: